| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 06/14/2006 | CN1259316C Heterocyclic compounds for aging-related and diabetic vascular complications |
| 06/14/2006 | CN1259315C Antagonists of MCP-1 function and methods of use thereof |
| 06/14/2006 | CN1259105C Buccal tablet of recombined human interferon alpha 2b and producing method |
| 06/14/2006 | CN1259063C Method for preparing non-specific immunity activator |
| 06/14/2006 | CN1259049C Composition for topical administration comprising an interleukin-2 inhibitor and an antimicrobial agent |
| 06/14/2006 | CN1259046C Soyisoflavone soft capsule and its preparation technology |
| 06/13/2006 | US7060845 Stabilized activated derivatives of carbamic acid, their process of preparation and their use for the preparation of ureas |
| 06/13/2006 | US7060836 Lactams as tachykinin antagonists |
| 06/13/2006 | US7060827 Intermediates useful for making 2,4-pyrimidinediamine compounds |
| 06/13/2006 | US7060824 Pyrrolotriazolopyrimidinone derivatives |
| 06/13/2006 | US7060802 Monoclonal antibody hybridomas ; detecting cancer |
| 06/13/2006 | US7060800 Polypeptides for use in the treatment and diagnosis of crohn's disease |
| 06/13/2006 | US7060731 Such as meglumine, 3-methylamino-1,2 propandiol or 2-(methylamino)-ethanol as complement inhibitors, to combact activation of the kinin/kallikrein system or as an anticoagulant |
| 06/13/2006 | US7060722 Proline derivatives and use thereof as drugs |
| 06/13/2006 | US7060720 Compounds useful for treating or preventing IMPDH associated disorders, such as transplant rejection and autoimmune diseases and inhibitors of inosine-5'-monophosphate dehydrogenase). The compounds and pharmaceutical compositions |
| 06/13/2006 | US7060716 Compound containing two triple bonds |
| 06/13/2006 | US7060705 2-(saturated N-heterocycylalkyl) quinazolinone compounds, e.g., 3-benzyl-2-[1-(4-methylpiperazin-1-yl)propyl]quinazolin-4(3H)-one, used to treat cancer, especially histiocytic lymphoma, lung adenocarcinoma, small cell lung cancer, pancreatic cancer, glioblastoma and breast carcinoma |
| 06/13/2006 | US7060701 piperidines or piperazines 1-linked to a 1-(1-carbonylpiperidin-4-yl)piperidinyl- group through an optionally substituted methyl group; treating Human Immuno-deficiency Virus, solid organ transplant rejection, arthritis, rheumatoid arthritis, and multiple sclerosis |
| 06/13/2006 | US7060700 Amide derivatives useful as inhibitors of the production of cytokines |
| 06/13/2006 | US7060687 Live vaccines for allergy treatment |
| 06/13/2006 | US7060685 Benzylaminosulfonic Acid or portion or analogue linked to a carbohydrate or glycomimetic for modulating processes mediated by selectin binding such as autoimmune and inflammatory diseases, shock and reperfusion injuries |
| 06/13/2006 | US7060675 Administering by mouth an effective amount of an insulin polypeptide derivative within one hour of ingestion of a meal by the patient to provide an insulin drug concentration in portal vein blood of 10-1,000 U/ml within 60 minutes |
| 06/13/2006 | US7060672 Cyclosporin analog formulations |
| 06/13/2006 | US7060498 Polycationic water soluble copolymer and method for transferring polyanionic macromolecules across biological barriers |
| 06/13/2006 | US7060470 Isoflavone-β-D-glucan produced by Agaricus blazei in the submerged liquid culture and method of producing same |
| 06/13/2006 | US7060447 Protein localization assays for toxicity and antidotes thereto |
| 06/13/2006 | US7060285 Dispersions for the formulation of slightly or poorly soluble agents |
| 06/13/2006 | US7060284 Polypeptides and polynucleotides for enhancing immune reactivity to HER-2 protein |
| 06/13/2006 | US7060279 Compositions and methods for dendritic cell-based immunotherapy |
| 06/13/2006 | US7060265 Cloning and recombinant production of polistinae venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon |
| 06/13/2006 | US7060262 Administering granulocyte colony stimulating factor; Crohn's disease |
| 06/13/2006 | US7060261 Nucleotide sequences coding polypeptide for us ein the treatment of immunological disorders |
| 06/13/2006 | US7060254 Aerosol; heating thin film on solid support; vaporization with air flow |
| 06/08/2006 | WO2006060507A2 Compositions comprising immunomodulatory compounds and the use thereof for the treatment of immunodeficiency disorders |
| 06/08/2006 | WO2006059785A1 Development of bioactive agent using dendritic cell differentiation-inducing factor |
| 06/08/2006 | WO2006059176A1 Naturally occuring igm antibodies that bind lymphocytes |
| 06/08/2006 | WO2006059142A1 Composition comprising phosphatidyl serine and an antigen or allergen and the use thereof |
| 06/08/2006 | WO2006059104A1 Herbal compositions comprising fructus crataegi, semen zizyphus, fructus schizandrae and panax ginseng |
| 06/08/2006 | WO2006040451A3 Novel 9h-pyrido[2,3-b]indole derivatives serving as cdk and gsk3 inhibitors, method for the preparation thereof, and the pharmaceutical compositions containing such compounds |
| 06/08/2006 | WO2006012508A3 Method of treating sjögren's syndrome |
| 06/08/2006 | WO2005116067A3 Msh-agonist tripeptide conjugates |
| 06/08/2006 | WO2005092926A3 Reducing the risk of human and anti-human antibodies through v gene manipulation |
| 06/08/2006 | US20060122392 Tri-heterocyclic compounds and a pharmaceutical comprising them as an active ingredient |
| 06/08/2006 | US20060122390 Boronic ester and acid compounds, synthesis and uses |
| 06/08/2006 | US20060122374 Albumin-fused anti-angiogenesis peptides |
| 06/08/2006 | US20060122264 Stem cell invasion inhibitor |
| 06/08/2006 | US20060122249 Condensed heterocyclic pyrazole derivatives as kinase inhibitors |
| 06/08/2006 | US20060122245 Novel inhibitors of IMPDH enzyme |
| 06/08/2006 | US20060122243 Antiallergic |
| 06/08/2006 | US20060122234 Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors |
| 06/08/2006 | US20060122221 N-[4-methyl-3-(3-piperidin-4-yl-1,2-benzisoxazol-6-yl)phenyl]-2-pyrrolidin-1-ylisonicotinamide; rheumatoid arthritis |
| 06/08/2006 | US20060122212 Bicyclic heteroaromatic compounds as kinase inhibitors |
| 06/08/2006 | US20060122176 such as 5-(1,3-benzodioxol-5-ylmethylene)-1,3-thiazolidine-2,4-dione, used for the treatment and/or prophylaxis of autoimmune, cardiovascular or neurodegenerative disorders, inflammatory or kidney diseases, bacterial or viral infections, platelet aggregation, cancer, transplant rejection or lung injuries |
| 06/08/2006 | US20060122107 Method of modulating cellular activity and molecules for use therein |
| 06/08/2006 | US20060121538 Peptides having affinity for the gp120 viral protein and use thereof |
| 06/08/2006 | US20060121529 CpG receptor (CpG-R) and methods relating thereto |
| 06/08/2006 | US20060121514 Prostacyclin-stimulating Factor-2 |
| 06/08/2006 | US20060121484 From mouse bone marrow; immunoglobulins; vectors, host cells; allergies |
| 06/08/2006 | US20060121132 TNF-alpha production inhibitor comprising kavalactone as an active ingredient |
| 06/08/2006 | US20060121079 Delivering a dose of gold, silver or an alloy of particles having a cross-sectional diameter of >20 mu m and the same weight but a greater surface area than that of solid spheres; direct contact with tissue to release ions for uptake by macrophages without phagocytosis of particles; immunocompetence |
| 06/08/2006 | US20060121030 Use of cd 137 antagonists for the treatment of tumors |
| 06/08/2006 | US20060121029 Method and composition for regulating the activity of regulatory t cells |
| 06/08/2006 | US20060121028 Variant IgG3 RITUXAN and therapeutic uses thereof |
| 06/08/2006 | US20060121015 Probiotic bifidobacterium strains |
| 06/08/2006 | DE202006001275U1 Herbal combination, useful against lactose intolerance, comprises herbal powders of absinth, anise, caraway, coriander, turmeric, fennel, blood wort, burnet root, juniper and lime pomace |
| 06/08/2006 | DE102004023778A1 Verwendung von Wirkstoffkomplexen aus Pflanzen der Familie Zosteraceae Use of active compound complexes from plants of the family Zosteraceae |
| 06/08/2006 | CA2588990A1 Compositions comprising immunomodulatory compounds and the use thereof for the treatment of immunodeficiency disorders |
| 06/08/2006 | CA2588195A1 Novel antiviral and immune stimulant pharmaceutical composition |
| 06/08/2006 | CA2587247A1 Composition comprising phosphatidyl serine and an antigen or allergen and the use thereof |
| 06/08/2006 | CA2580801A1 Naturally occuring igm antibodies that bind lymphocytes |
| 06/07/2006 | EP1666589A1 Process for producing cytotoxic lymphocytes |
| 06/07/2006 | EP1666498A2 Soluble CTLA4 molecules, compositions comprising said molecules and uses thereof |
| 06/07/2006 | EP1666481A2 Optical resolution of (1-benzyl-4-methylpiperidin-3-yl)-methylamine and the use thereof for the preparation of pyrrolo[2,3]pyrimidine derivatives as protein kinases inhibitors |
| 06/07/2006 | EP1666480A1 Aryl or Heteroaryl Fused Imidazole Compounds as intermediates for Anti-Inflammatory And Analgesic Agents. |
| 06/07/2006 | EP1666473A1 Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient |
| 06/07/2006 | EP1666465A1 Composition comprising a tachykinin receptor antagonist and a selective serotonin reuptake inhibitor |
| 06/07/2006 | EP1666092A2 Drug combination comprising a fatty acid and a uridine compound. |
| 06/07/2006 | EP1666065A1 Therapeutic agent for autoimmune disease |
| 06/07/2006 | EP1666063A2 Method for treatment of fibrosis using an antagonist of the integrin alpha-4 subunit |
| 06/07/2006 | EP1666062A2 Therapeutic applications for the anti-T-BAM (CD40-L) monoclonal antibody 5c8 |
| 06/07/2006 | EP1666060A1 Adjuvant systems and vaccines |
| 06/07/2006 | EP1666056A1 Cancer vaccine vesicles |
| 06/07/2006 | EP1666052A1 Uses of agonists and antagonists to modulate activity of TNF-related molecules |
| 06/07/2006 | EP1666050A1 Use of enrerococcus faecium strains for curing hepatic insufficiency and for regenerating and intensifying metabolism in a liver |
| 06/07/2006 | EP1666047A1 Pharmaceutical compositions comprising nitric oxide-releasing pyrrolidones |
| 06/07/2006 | EP1666039A1 Use of L-alpha-lysophosphatidylcholine inhibitors to prevent inflammation |
| 06/07/2006 | EP1666028A1 Dry powder compositions having improved dispersivity |
| 06/07/2006 | EP1664122A2 Therapeutic binding molecules against cd45 isoforms |
| 06/07/2006 | EP1664003A1 Haloalkyl containing compounds as cysteine protease inhibitors |
| 06/07/2006 | EP1663983A1 N-substituted, 6,8-dialkoxy-1,2,3,4-tetrahydro-1h-isoquinoline as potassium channels modulators |
| 06/07/2006 | EP1663966A1 1,3-disubstituted azetidine derivatives for use as ccr-3 receptor antagonists in the treatment of inflammatory and allergic diseases |
| 06/07/2006 | EP1663308A1 Compositions and methods to accelerate hematologic recovery |
| 06/07/2006 | EP1663306A2 Antibodies with altered effector functions |
| 06/07/2006 | EP1663290A2 Modulators of p-selectin glycoprotein ligand 1 |
| 06/07/2006 | EP1663258A2 Pharmaceutical compositions and therapeutic treatment with oligo-beta- (1,3) - glucans |
| 06/07/2006 | EP1663249A1 1,3-DIACLYATED,26,27-ALKYL/HALOALKYL VITAMIN D sb 3 /sb COMPOUNDS AND METHODS OF USE THEREOF |
| 06/07/2006 | EP1663222A1 Methods related to the treatment of mucosal associated conditions |
| 06/07/2006 | EP1663217A1 Solid dispersions comprising tacrolimus |
| 06/07/2006 | EP1663216A1 Modified release compositions comprising tacrolimus |
| 06/07/2006 | EP1663198A1 Pharmaceutical formulations of xanthogenates and inhibitors of viral nucleic acid replication (e.g. aciclovir) |